G. Spignoli

748 total citations
29 papers, 625 citations indexed

About

G. Spignoli is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, G. Spignoli has authored 29 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in G. Spignoli's work include Neuroscience and Neuropharmacology Research (13 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Memory and Neural Mechanisms (5 papers). G. Spignoli is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Memory and Neural Mechanisms (5 papers). G. Spignoli collaborates with scholars based in Italy. G. Spignoli's co-authors include Giancarlo Pepeu, Felicita Pedata, Maria Grazia Giovannini, Lisa Giovannelli, Mauro Magnani, Francesca Paoli, G Pepeu, V. Carla�, Flavio Moroni and Domenico Barone and has published in prestigious journals such as British Journal of Pharmacology, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

G. Spignoli

28 papers receiving 590 citations

Peers

G. Spignoli

CMN

PHARM

PHYSI

Andrea M. Martino United States

R. M. Denney United States

Vincenzo Di Matteo Italy

Andres D. Ramirez United States

Helmut A. Ensinger Germany

Anna Dziubina Poland

Silva Fredduzzi Italy

Mary Cohen-Williams United States

J. Ułas United States

Yotam Sagi United States

Andrea M. Martino United States

G. Spignoli

498 ×1.4

CMN

546 ×2.1

231 ×1.1

PHARM

116 ×0.9

152 ×2.0

PHYSI

Citations per year, relative to G. Spignoli G. Spignoli (= 1×) peers Andrea M. Martino

Countries citing papers authored by G. Spignoli

Since Specialization

Citations

This map shows the geographic impact of G. Spignoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Spignoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Spignoli more than expected).

Fields of papers citing papers by G. Spignoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Spignoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Spignoli. The network helps show where G. Spignoli may publish in the future.

Co-authorship network of co-authors of G. Spignoli

This figure shows the co-authorship network connecting the top 25 collaborators of G. Spignoli. A scholar is included among the top collaborators of G. Spignoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Spignoli. G. Spignoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Altavilla, Domenica, F. Squadrito, Mariapatrizia Ioculano, et al.. (1995). G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-α biosynthesis. European Journal of Pharmacology. 286(1). 31–39. 15 indexed citations

Squadrito, Francesco, Mariapatrizia Ioculano, Basilia Zingarelli, et al.. (1993). G 619, a Dual Thromboxane Synthase Inhibitor and Thromboxane A<sub>2</sub> Receptor Antagonist, Reduces Myocardial Damage and Polymorpho-nuclear Leukocyte Accumulation following Coronary Artery Occlusion and Reperfusion in Rats. Pharmacology. 47(3). 167–175. 4 indexed citations

Calapai, Gioacchino, F. Squadrito, Giuseppe M. Campo, et al.. (1993). Effects of pretreatment with G 619, a dual inhibitor of thromboxane A2 synthase and thromboxane A2 receptor antagonist, on cerebral ischemia in the Mongolian gerbil. 12(2). 109–118. 1 indexed citations

Squadrito, Francesco, Domenica Altavilla, Basilia Zingarelli, et al.. (1992). Protective Effects of G 619, a Dual Thromboxane Synthase Inhibitor and Thromboxane A2 Receptor Antagonist, in Splanchnic Artery Occlusion Shock. Journal of Cardiovascular Pharmacology. 19(1). 115–119. 12 indexed citations

Tullio, Viviana Cristina, et al.. (1991). New imidazole derivates: in-vitro activity on dermatophytes.. PubMed. 3 Suppl 1. 43–6. 1 indexed citations

Simonetti, N, G. Spignoli, Felicia Diodata D’Auria, & V. Strippoli. (1991). Antimicrobial Contact Activity of Econazole Sulfosalicylate. Journal of Chemotherapy. 3(2). 101–107. 2 indexed citations

Spignoli, G., et al.. (1991). A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine. Pharmacological Research. 24(4). 395–405. 19 indexed citations

Paoli, Francesca, G. Spignoli, & Giancarlo Pepeu. (1990). Oxiracetam andd-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-d-aspartate receptor antagonist 2-amino-5-phosphonovalerate. Psychopharmacology. 100(1). 130–131. 27 indexed citations

Quattropani, Maria C., et al.. (1990). Pyroglutamic acid improves the age associated memory impairment. Fundamental and Clinical Pharmacology. 4(2). 169–173. 26 indexed citations

10.

Spignoli, G., et al.. (1989). Nootropic drugs and brain cholinergic mechanisms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 13. S77–S88. 52 indexed citations

11.

Pepeu, Giancarlo, G. Spignoli, Maria Grazia Giovannini, & Mauro Magnani. (1989). The Relationship Between the Behavioral Effects of Cognition-Enhancing Drugs and Brain Acetylcholine. Pharmacopsychiatry. 22(S 2). 116–119. 19 indexed citations

12.

Spignoli, G. & Giancarlo Pepeu. (1987). Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacology Biochemistry and Behavior. 27(3). 491–495. 106 indexed citations

13.

Zuccato, Ettore, et al.. (1987). Evidence of a lack of enteric side-effects induced by DEAE-dextran in man. Pharmacological Research Communications. 19(8). 547–553. 1 indexed citations

14.

Spignoli, G., Mauro Magnani, Maria Grazia Giovannini, & Giancarlo Pepeu. (1987). Effect of pyroglutamic acid stereoisomers on ecs and scopolamine-induced memory disruption and brain acetylcholine levels in the rat. Pharmacological Research Communications. 19(12). 901–912. 20 indexed citations

15.

Zuccato, Ettore, et al.. (1987). Investigation on the fate of orally administered deae-dextran in rats. Pharmacological Research Communications. 19(6). 405–413. 2 indexed citations

16.

Pepeu, G & G. Spignoli. (1986). Effect of oxiracetam on cognition and brain cholinergic mechanisms.. PubMed. 9 Suppl 4. 298–300. 1 indexed citations

17.

Spignoli, G., et al.. (1986). Effect of Oxiracetam and Piracetam on Central Cholinergic Mechanisms and Active-Avoidance Acquisition. Clinical Neuropharmacology. 9. S39–47. 24 indexed citations

18.

Pedata, Felicita, Lisa Giovannelli, G. Spignoli, Maria Grazia Giovannini, & Giancarlo Pepeu. (1985). Phosphatidylserine increases acetylcholine release from cortical slices in aged rats. Neurobiology of Aging. 6(4). 337–339. 51 indexed citations

19.

Pedata, Felicita, Giancarlo Pepeu, & G. Spignoli. (1984). Biphasic effect of methylxanthines on acetylcholine release from electrically‐stimulated brain slices. British Journal of Pharmacology. 83(1). 69–73. 27 indexed citations

20.

Pedata, Felicita, et al.. (1984). Effect of adenosine and caffeine on acetylcholine release from electrically stimulated brain slices.. PubMed. 20(1). 33–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact